{"url_path":"/sec/hims/8-k/2026-05-19/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-19","source_url":"https://www.sec.gov/Archives/edgar/data/1773751/0001193125-26-229749-index.html","accession_number":"0001193125-26-229749","cik":"0001773751","ticker":"HIMS","issuer_name":"Hims & Hers Health, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1773751/0001193125-26-229749-index.html","primary_entity_key":"0001773751","primary_entity_name":"Hims & Hers Health, Inc."},"word_count":187,"has_tables":true,"body_markdown":"Item 8.01. Other Events.\n\nOn May 18, 2026, Hims & Hers Health, Inc. (the “Company”) issued a press release relating to its proposed private offering of Convertible Senior Notes due 2032 to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference in this Item 8.01.\n\nOn May 18, 2026, the Company issued a press release relating to the pricing of its private offering of 0.00% Convertible Senior Notes due 2032 (the “Notes”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act. A copy of the press release is attached as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated by reference in this Item 8.01.\n\nNeither this Current Report on Form 8-K nor the press releases constitute an offer to sell, or the solicitation of an offer to buy, the Notes or the shares of the Company’s Class A common stock, if any, issuable upon conversion of the Notes."}